Although targeting PD‐1/PD‐L1 therapies have recently developed rapidly in tumor treatment for various cancers, however, single targeting PD‐1/PD‐L1 therapy is not effective in pancreatic cancer.49 This evidence concerns the gene CD274 and familial pancreatic carcinoma.